RXI PHARMACEUTICALS CORP·4

Jul 16, 2:34 PM ET

Pavco Pamela 4

4 · RXI PHARMACEUTICALS CORP · Filed Jul 16, 2010

Insider Transaction Report

Form 4
Period: 2010-07-15
Pavco Pamela
VP of Pharmaceutical Devlpmt.
Transactions
  • Award

    Common Stock

    2010-07-15$2.38/sh+5,000$11,92111,377 total
Footnotes (1)
  • [F1]The purchase price reported in this Form 4 was between the range of $2.36 per share and $2.39 per share. Full information regarding the number of shares purchased at each seperate price will be provided to the Commission staff upon request.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_339236

    POA DOCUMENT